DEBRISOQUINE OXIDATION PHENOTYPE AND SUSCEPTIBILITY TO LUNG-CANCER

被引：12

作者：

BOOBIS, AR

DAVIES, DS

机构：

[1] Academic Department of Medicine, Royal Free Hospital School of Medicine, London

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1990年 / 30卷 / 04期

关键词：

D O I：

10.1111/j.1365-2125.1990.tb03832.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

收藏

页码：653 / 656

页数：4

相关论文

共 20 条

[1] ALVAN G, 1990, IN PRESS EUR J CLIN
[2] METABOLIC OXIDATION PHENOTYPES AS MARKERS FOR SUSCEPTIBILITY TO LUNG-CANCER
AYESH, R
IDLE, JR
RITCHIE, JC
CROTHERS, MJ
HETZEL, MR
[J]. NATURE, 1984, 312 (5990) : 169 - 170
[3] BOOBIS AR, 1987, 10TH INT C PHARM SYD, pO335
[4] THE RATIONALE FOR CASE-CONTROL METHODOLOGY IN EPIDEMIOLOGIC STUDIES OF CANCER RISK - RESPONSE
CAPORASO, N
IDLE, JR
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 30 (01) : 149 - 150
[5] CAPORASO N, 1989, CANCER RES, V49, P3675
[6] THE DISTRIBUTION OF DEBRISOQUINE METABOLIC PHENOTYPES AND IMPLICATIONS FOR THE SUGGESTED ASSOCIATION WITH LUNG-CANCER RISK
CAPORASO, N
PICKLE, LW
BALE, S
AYESH, R
HETZEL, M
IDLE, J
[J]. GENETIC EPIDEMIOLOGY, 1989, 6 (04) : 517 - 524
[7] CAPORASO N, 1988, 24TH AM SOC CLIN ONC, V7, P336
[8] A FAMILY AND POPULATION STUDY OF THE GENETIC-POLYMORPHISM OF DEBRISOQUINE OXIDATION IN A WHITE BRITISH-POPULATION
EVANS, DAP
MAHGOUB, A
SLOAN, TP
IDLE, JR
SMITH, RL
[J]. JOURNAL OF MEDICAL GENETICS, 1980, 17 (02) : 102 - 105
[9] HYPOTENSIVE RESPONSE TO DEBRISOQUINE AND HYDROXYLATION PHENOTYPE
IDLE, JR
MAHGOUB, A
LANCASTER, R
SMITH, RL
[J]. LIFE SCIENCES, 1978, 22 (11) : 979 - 983
[10] GENETIC PREDISPOSITION TO LUNG-CANCER
LAW, MR
[J]. BRITISH JOURNAL OF CANCER, 1990, 61 (02) : 195 - 206